4年融资超60亿,创新药龙头君实生物为何还“缺钱”?

尺度商业
Jun 13, 2025

来源:尺度财经作者:杨万里6月13日早间,创新药龙头君实生物发布了新的港股融资计划。一边是净利润持续亏损,一边是持续融资加码研发管线,目前君实生物的盈利困局暂时未解。截至收盘,君实生物(A股)股价收跌6.65%,总市值收报355.6亿元。近4年融资超60亿,又抛出港股配售计划6月13日,君实生物在港交所发布公告称,拟配售4100万股新H股,预计净筹约10.26亿港元(按当前汇率,折合人民币约9.4...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10